The Improvement of the Metabolic Regulation in a Diabetic Patient With Pulmonary Sarcoidosis Treated With Steroid

After receiving a diagnosis of type 2 diabetes, he was diagnosed with lung sarcoidosis and steroid treatment, we present a case with chronic active hepatic disease and difficulty in metabolic control. Thirty-two-year-old male patient was diagnosed with type 2 diabetes and diagnosed with L？fgren’s syndrome while metabolic control was good under metformin treatment. Steroid therapy started because of lung involvement. Oral antidiabetics were not used because of active liver disease. Hyperglycemia became evident when clinic and lung findings were improved. For this reason, metabolic control was attempted with basal / bolus insulin therapy. When steroid doses of uncomplicated diabetic patients are reduced, blood glucose levels were also at optimal levels. High dose, longterm steroid use and diabetes mellitus association may lead to impaired blood glucose control in chronic lung diseases and increased complications. As in our case, it is recommended that the dose of the steroid be lowered to the lowest possible dose in the best possible time, without disrupting the treatment of diabetic patients.In addition, the use of alternative therapies instead of steroids will play an important role in the control of blood glucose levels